Mavacamten Real-World Effectiveness and Safety in Obstructive Hypertrophic Cardiomyopathy

This study focuses on evaluating the effectiveness and safety of a medication called mavacamten in patients with a heart condition known as obstructive hypertrophic cardiomyopathy (oHCM) in Japan. The goal is to understand how well the drug works in real-world settings for individuals with this specific condition. The study is important as it aims to provide insights into the drug's performance outside of controlled clinical trials, potentially improving care for those with oHCM. Participants in this observational study will be monitored while receiving mavacamten treatment. The study will keep track of any adverse events or serious adverse events that may occur, and the actions taken in response to these events. It will also measure the incidence and outcome of these events, providing a comprehensive understanding of the drug's safety profile in a real-world context.